Estonia - Estonian - Ravimiamet

glaxosmithkline (ireland) limited - flutikasoon - kreem - 500mcg 1g 30g 1tk; 500mcg 1g 15g 1tk

Estonia - Estonian - Ravimiamet

glaxosmithkline (ireland) limited - flutikasoon - salv - 50mcg 1g 15g 1tk

Estonia - Estonian - Ravimiamet

first pharma oÜ - hüdroksüklorokviin - õhukese polümeerikattega tablett - 200mg 60tk

Estonia - Estonian - Ravimiamet

accord healthcare b.v. - hüdroksüklorokviin - õhukese polümeerikattega tablett - 200mg 20tk; 200mg 60tk; 200mg 90tk; 200mg 100tk; 200mg 30tk; 200mg 50tk

European Union - Estonian - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaktsiinid - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.

Estonia - Estonian - Ravimiamet

lex ano uab - hüdroksüklorokviin - õhukese polümeerikattega tablett - 200mg 60tk; 200mg 30tk

Estonia - Estonian - Ravimiamet

ideal trade links uab - hüdroksüklorokviin - õhukese polümeerikattega tablett - 200mg 30tk; 200mg 60tk

Estonia - Estonian - Ravimiamet

bausch health ireland limited - meropeneem - süste-/infusioonilahuse pulber - 1000mg 10tk

Estonia - Estonian - Ravimiamet

bausch health ireland limited - meropeneem - süste-/infusioonilahuse pulber - 500mg 10tk